Bauer L A, Blouin R A
Antimicrob Agents Chemother. 1981 Nov;20(5):587-9. doi: 10.1128/AAC.20.5.587.
The influence of age on tobramycin half-life, volume of distribution, and clearance was examined in 77 patients with infections due to gram-negative bacteria. All patients had normal renal function and hematocrits, were within 20% of their ideal body weight, did not receive penicillin antibiotics concurrently, and had a fever. Twenty-five patients were between 20 and 39 years of age, 23 patients were 40 to 59 years old, and 29 patients were in the age group 60 to 79 years. The mean half-lives were 2.3, 2.2, and 2.4 h, respectively, for the three age groupings. The average clearance and volume of distribution terms were, respectively, 1.34 ml/min per kg and 0.25 liter/kg for the younger group, 1.44 ml/min per kg and 0.26 liter/kg for the middle age group, and 1.25 ml/min per kg and 0.25 liter/kg for the older group. There was no significant difference among the three groups for any of the parameters (P less than 0.05, analysis of variance). Correlation coefficients determined from individual plots of the three pharmacokinetic parameters versus age revealed no correlation between any parameter and age. Forty-five percent of the patients required doses greater than the recommended maximum (5 mg/kg per day) to achieve desired steady-state concentrations. Since tobramycin pharmacokinetics do not change as age increased, doses do not need to be arbitrarily changed in older patients with normal renal function.
在77例革兰氏阴性菌感染患者中,研究了年龄对妥布霉素半衰期、分布容积和清除率的影响。所有患者肾功能和血细胞比容均正常,体重在理想体重的20%以内,未同时接受青霉素类抗生素治疗,且均有发热症状。25例患者年龄在20至39岁之间,23例患者年龄为40至59岁,29例患者年龄在60至79岁之间。三个年龄组的平均半衰期分别为2.3小时、2.2小时和2.4小时。年轻组的平均清除率和分布容积分别为每千克体重1.34毫升/分钟和0.25升/千克,中年组为每千克体重1.44毫升/分钟和0.26升/千克,老年组为每千克体重1.25毫升/分钟和0.25升/千克。三组之间的任何参数均无显著差异(方差分析,P<0.05)。根据三个药代动力学参数与年龄的个体图确定的相关系数显示,任何参数与年龄之间均无相关性。45%的患者需要高于推荐最大剂量(5毫克/千克/天)才能达到所需的稳态浓度。由于妥布霉素的药代动力学不会随着年龄的增加而改变,因此肾功能正常的老年患者无需随意调整剂量。